Save your place

Sign in to WhoBought

Please try again later.

Elevance Health Inc. (ELV) institutional ownership

Latest close $375.84 Jul 31, 2026
Market cap$84.3B 52-week range SectorHealthcare
Institutional ownership · Q1 2026
88.3%
of ELV shares outstanding
Top owners · Q1 2026
Wellington Management Group LLP
Sanders Capital, LLC
Artisan Partners Limited Partnership
Institutional activity · Q1 2026
Net sold $2.2B
609 buyers · 848 sellers

Elevance Health Inc. (ELV) price and institutional activity

Dates

Q1 2026

$4.1B bought by 609 investors
Amundi$525MInvesco Ltd.$300M +607 more
$6.3B sold by 848 investors
Norges-$992MT. Rowe Price Associates-$887M +846 more
Bought Sold Totals per quarter; hover a bar for the names.

Elevance Health Inc. (ELV) ownership

Largest disclosed holders in Q1 2026.

13F filing season in progress; institutional ownership uses the last closed quarter (2026 Q1)

Active funds 59.0%Index funds 29.3%Insiders 0.2%Retail and other 11.5%

Wellington Management Group LLP

owns 3.8% of shares outstanding
Est. $3.2B · Shares: 8.2M

Sanders Capital, LLC

owns 2.7% of shares outstanding
Est. $2.3B · Shares: 5.9M

Artisan Partners Limited Partnership

owns 2.4% of shares outstanding
Est. $2.0B · Shares: 5.1M

Invesco Ltd.

View investor →
owns 2.2% of shares outstanding
Est. $1.9B · Shares: 4.8M

Harris Associates L P

owns 2.2% of shares outstanding
Est. $1.9B · Shares: 4.8M

T. Rowe Price Associates

owns 2.2% of shares outstanding
Est. $1.8B · Shares: 4.7M

First Eagle Investment Management, LLC

owns 1.9% of shares outstanding
Est. $1.6B · Shares: 4.1M

Bank of New York Mellon Corp

owns 1.3% of shares outstanding
Est. $1.1B · Shares: 2.8M

Elevance Health Inc. (ELV) institutional activity · 1,457

Investor Type Est. change Change Δ Own Date
Norges · Exited −$992M
Change −3.0M Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −$992M −3.0M −100.0% Q1 2026
T. Rowe Price Associates · Reduced −$887M
Change −2.7M Date Q1 2026
T. Rowe Price Associates Reduced· Q1 2026 −$887M −2.7M Q1 2026
Amundi · Added +$525M
Change +1.6M Date Q1 2026
Amundi Added· Q1 2026 +$525M +1.6M Q1 2026
Orbis Allan Gray Ltd · Reduced −$349M
Change −1.1M Date Q1 2026
Orbis Allan Gray Ltd Reduced· Q1 2026 −$349M −1.1M Q1 2026
Invesco Ltd. · Added +$300M
Change +914K Δ Own +23.4% Date Q1 2026
Invesco Ltd. Added· Q1 2026 +$300M +914K +23.4% Q1 2026
Baillie Gifford & Co · Reduced −$265M
Change −805K Date Q1 2026
Baillie Gifford & Co Reduced· Q1 2026 −$265M −805K Q1 2026
Grantham, Mayo, van Otterloo & Co. LLC Reduced· Q1 2026 −$195M −593K −23.4% Q1 2026
SG Americas Securities, LLC · Added +$184M
Change +561K Date Q1 2026
SG Americas Securities, LLC Added· Q1 2026 +$184M +561K Q1 2026
Capital International Investors · Reduced −$176M
Change −537K Date Q1 2026
Capital International Investors Reduced· Q1 2026 −$176M −537K Q1 2026
BlackRock · Reduced −$169M
Change −516K Date Q1 2026
BlackRock Reduced· Q1 2026 −$169M −516K Q1 2026
Bank of America Corp · Added +$168M
Change +512K Date Q1 2026
Bank of America Corp Added· Q1 2026 +$168M +512K Q1 2026
FMR LLC · Added +$163M
Change +496K Δ Own +33.6% Date Q1 2026
FMR LLC Added· Q1 2026 +$163M +496K +33.6% Q1 2026
Eminence Capital, LP · Exited −$160M
Change −487K Δ Own −100.0% Date Q1 2026
Eminence Capital, LP Exited· Q1 2026 −$160M −487K −100.0% Q1 2026
Millennium Management LLC · Added +$153M
Change +466K Date Q1 2026
Millennium Management LLC Added· Q1 2026 +$153M +466K Q1 2026
Barclays PLC · Added +$151M
Change +460K Date Q1 2026
Barclays PLC Added· Q1 2026 +$151M +460K Q1 2026
Data through Q1 2026 · filed Jun 11, 2026
15 of 1457

Famous investor activity in Elevance Health Inc. (ELV)

Elevance Health Inc. (ELV) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Peru Ramiro G. · Director Buy +$366K
Price $366.05 Qty +1K Owned 11K ΔOwn +10.1% Trade date Jul 17, 2026 Filed date Jul 17, 2026
Peru Ramiro G. Director Buy $366.05 +1K +$366K 11K +10.1% Jul 17, 2026 Jul 17, 2026
Boudreaux Gail · Director 2 operations +$1.0M
Price $366.41–$368.25 Qty +3K Owned 172K ΔOwn +1.6% Trade date Jul 17, 2026 Filed date Jul 17, 2026
Boudreaux Gail Director 2 operations $366.41–$368.25 +3K +$1.0M 172K +1.6% Jul 17, 2026 Jul 17, 2026
Penczek Ronald W. · Officer Sell −$149K
Price $403.16 Qty −369 Owned 4K Trade date Jun 12, 2026 Filed date Jun 15, 2026
Penczek Ronald W. Officer Sell $403.16 −369 −$149K 4K Jun 12, 2026 Jun 15, 2026
Dixon Robert L. Jr · Director Sell −$61K
Price $401.77 Qty −151 Owned 11K Trade date Jun 11, 2026 Filed date Jun 12, 2026
Dixon Robert L. Jr Director Sell $401.77 −151 −$61K 11K Jun 11, 2026 Jun 12, 2026
Penczek Ronald W. · Officer Sell −$617K
Price $403.13 Qty −2K Owned 4K Trade date May 19, 2026 Filed date May 20, 2026
Penczek Ronald W. Officer Sell $403.13 −2K −$617K 4K May 19, 2026 May 20, 2026
Penczek Ronald W. · Officer 4 operations 0
Price $271.27–$311.48 Owned 0 Trade date May 19, 2026 Filed date May 20, 2026
Penczek Ronald W. Officer 4 operations $271.27–$311.48 0 0 May 19, 2026 May 20, 2026
Strable-Soethout Deanna D. · Director Grant (A) 563
Owned 2K Trade date May 13, 2026 Filed date May 15, 2026
Strable-Soethout Deanna D. Director Grant (A) 563 2K May 13, 2026 May 15, 2026
Schulman Amy W. · Director Grant (A) 563
Owned 781 Trade date May 13, 2026 Filed date May 15, 2026
Schulman Amy W. Director Grant (A) 563 781 May 13, 2026 May 15, 2026
Schneider Ryan M. · Director Grant (A) 563
Owned 7K Trade date May 13, 2026 Filed date May 15, 2026
Schneider Ryan M. Director Grant (A) 563 7K May 13, 2026 May 15, 2026
Peru Ramiro G. · Director Grant (A) 563
Owned 10K Trade date May 13, 2026 Filed date May 15, 2026
Peru Ramiro G. Director Grant (A) 563 10K May 13, 2026 May 15, 2026
Neri Antonio F. · Director Grant (A) 563
Owned 5K Trade date May 13, 2026 Filed date May 15, 2026
Neri Antonio F. Director Grant (A) 563 5K May 13, 2026 May 15, 2026
Jallal Bahija · Director Grant (A) 563
Owned 5K Trade date May 13, 2026 Filed date May 15, 2026
Jallal Bahija Director Grant (A) 563 5K May 13, 2026 May 15, 2026
Hay Lewis III · Director Grant (A) 563
Owned 12K Trade date May 13, 2026 Filed date May 15, 2026
Hay Lewis III Director Grant (A) 563 12K May 13, 2026 May 15, 2026
Dixon Robert L. Jr · Director Grant (A) 563
Owned 11K Trade date May 13, 2026 Filed date May 15, 2026
Dixon Robert L. Jr Director Grant (A) 563 11K May 13, 2026 May 15, 2026
Devore Susan D. · Director Grant (A) 563
Owned 4K Trade date May 13, 2026 Filed date May 15, 2026
Devore Susan D. Director Grant (A) 563 4K May 13, 2026 May 15, 2026
15 of 52
15 of 52 Sign in to continue to older insider transactions.

Elevance Health Inc. (ELV) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Vanguard Group Inc 21.2M
% of shares outstanding 9.0% Filing date Feb 13, 2024
Vanguard Group Inc 21.2M 9.0% Feb 13, 2024
BlackRock Inc. 21.0M
% of shares outstanding 9.0% Filing date Feb 12, 2024
BlackRock Inc. 21.0M 9.0% Feb 12, 2024
Vanguard Capital Management 16.6M
% of shares outstanding 7.1% Filing date Apr 29, 2026
Vanguard Capital Management 16.6M 7.1% Apr 29, 2026
T. Rowe Price Associates 10.2M
% of shares outstanding 4.4% Filing date Nov 14, 2024
T. Rowe Price Associates 10.2M 4.4% Nov 14, 2024
4 of 4

Elevance Health Inc. (ELV) ownership FAQ

Who owns ELV?

Institutions hold 88.3% of ELV shares in the Q1 2026 snapshot. The largest disclosed owners include Wellington Management Group LLP, Sanders Capital, LLC, Artisan Partners Limited Partnership. The ownership chart shows each group's share of total shares outstanding from the latest disclosed filings. Retail and other includes everyone who does not file, not a tracked group.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.